Loading...
Next Generation Biologics Will Transform Global Regenerative Care
AnalystHighTarget's Fair Value
US$6.00
85.0% undervalued intrinsic discount24 Aug
US$0.90
1Y
-72.5%7D
0.3%1Y
-72.5%7D
0.3%You can edit this narrative until Aug 24 9:49 PM. Then, changes will post as Updates.